The disposable ostomy bags market size is expected to increase from USD 2.66 billion in 2025 to USD 2.83 billion in 2026 and reach USD 3.76 billion by 2031, growing at a CAGR of 5.84% over 2026-2031. This report is segmented by Product Type (One-Piece, Two-Piece), Ostomy Type (Colostomy, Ileostomy, Urostomy), System Design (Drainable, Closed-End, Flat, Convex), Indication (Colorectal Cancer, IBD, Bladder Cancer, Others), End User (Hospitals, Ascs, Home-Care, Long-Term Care), and Geography (North America, South America, Europe, Asia-Pacific, Middle East, Africa).
Other drivers and restraints analyzed in the detailed report include:
Two-piece systems are forecast to grow at a 6.8% CAGR through 2031. Their main benefit is that users can change the pouch without removing the baseplate. This can reduce repeated skin disturbance for patients managing peristomal skin problems. Coloplast continued to add accounts for its SenSura Mio two-piece offering in Europe and the United States through the first half of 2025/26. Telehealth consultations can also help clinicians review baseplate fit and recommend pouch-only changes, which favors modular systems.
Colostomy bags accounted for 52.8% of revenue in the disposable ostomy bags market in 2025. Their scale follows the close relationship between colorectal cancer surgery and the creation of temporary or permanent colostomies. Colorectal cancer remains one of the most common cancers worldwide, with an estimated 2 million new cases annually. The disposable ostomy bags industry relies on recurring use because many patients require ongoing management after surgery. Colostomy products, therefore, remain the core volume category.
Urostomy bags have the highest projected growth rate at 7.2% through 2031. Rising bladder cancer surgery volumes increase the need for urinary diversion products. Urinary diversions also have a lower reversal rate than intestinal ostomies, which extends the period of product use. Ileostomy bags maintain demand from Crohn’s disease and ulcerative colitis procedures. Inflammatory bowel disease rates are rising in areas that previously had lower disease burdens, including Southeast Asia and Latin America. Younger bladder cancer patients in parts of Asia may also raise demand for products that support active lifestyles.
Asia-Pacific is forecast to grow at a 7.5% CAGR through 2031, the fastest regional rate in the disposable ostomy bags market. China’s colorectal cancer burden, India’s hospital expansion, and Japan’s older population support regional demand. China has more than 1 million ostomy patients, with close to 100,000 new patients each year according to the source material. Japan combines an aging population with established reimbursement for stoma-care products, while South Korea, Australia, and New Zealand have well-developed branded product markets.
Europe has a substantial stoma population and established reimbursement structures, with Germany leading regional volumes. Coloplast reported double-digit growth in the United Kingdom during the first half of 2025/26, supported by SenSura Mio Convex. South America is led by Brazil as colorectal cancer treatment access improves. ConvaTec identified Latin America as a growth leader in its April 2026 trading update. The Middle East and Africa remain earlier-stage areas with rising awareness and more private hospital capacity.
Global Disposable Ostomy Bags Market Trends and Insights
Rising Colorectal Cancer and Inflammatory Bowel Disease Burden
The disposable ostomy bags market expands as cancer and chronic intestinal conditions increase the number of patients who may need ostomy surgery. Colorectal cancer accounted for 9.9% of new cancer cases worldwide in GLOBOCAN 2024, ranking third for incidence and second for mortality. The World Health Organization projects nearly 35 million new cancer cases a year by 2050, 67% above the 2024 level. Better use of biologics, immunotherapy, and targeted treatments has extended survival for many colorectal cancer patients, increasing the importance of products used over long periods. Global inflammatory bowel disease prevalence reached 3.83 million cases in 2021 after rising 85.1% from 1990. China recorded 517,106 new colorectal cancer cases in 2022, and its expanding patient pool strengthens the need for ongoing self-management supportExpansion of Home-Based Ostomy Management
Home-based management is a durable source of recurring demand in the disposable ostomy bags market. An estimated 750,000 to 1 million people in the United States use ostomy products, and close to 100,000 new ostomy surgeries occur annually. Specialized home health providers showed lower emergency room use and hospitalization than pharmacy-based care in an ISPOR 2025 study. This clinical and economic evidence supports payer decisions that direct patients toward supported home care. ConvaTec reported continued new patient starts through its Home Services Group in North America during 2025. A 2026 systematic review found that telehealth stoma care improved adjustment and self-efficacy, reinforcing the clinical systems that support patients outside hospitalsPeristomal Skin Complications and Product-Related Discomfort
Peristomal skin complications can raise replacement use but can also weaken confidence in ostomy appliances. Incidence estimates among patients with newly formed stomas ranged from 15.5% to 80%, while a 2025 Scientific Reports study found complications in 59.7% of patients 1 month after surgery. Patients may not recognize early changes in the skin, which increases reliance on trained wound, ostomy, and continence nurses. The uneven availability of these specialists can limit appropriate product fitting across regions. Product manufacturers must also support clinical evidence requirements for skin barriers and accessory devices under the European Union Medical Device Regulation 2017/745. These factors can increase development effort and slow the introduction of differentiated products.Other drivers and restraints analyzed in the detailed report include:
- Increasing Demand for Skin-Friendly and Leak-Resistant Designs
- Digital Leakage Detection and Anatomy-Customized Pouching Systems
- High Cost of Premium Multi-Piece Systems and Accessories
Segment Analysis
One-piece systems held 63.4% of the disposable ostomy bags market share in 2025. Their position reflects straightforward application, a lower profile, and easier daily management for home-care users. These features also suit many older patients and people who are learning self-care after surgery. One-piece products are supported by their lower cost in reimbursement-limited settings. This established base keeps the format central to the disposable ostomy bags market.Two-piece systems are forecast to grow at a 6.8% CAGR through 2031. Their main benefit is that users can change the pouch without removing the baseplate. This can reduce repeated skin disturbance for patients managing peristomal skin problems. Coloplast continued to add accounts for its SenSura Mio two-piece offering in Europe and the United States through the first half of 2025/26. Telehealth consultations can also help clinicians review baseplate fit and recommend pouch-only changes, which favors modular systems.
Colostomy bags accounted for 52.8% of revenue in the disposable ostomy bags market in 2025. Their scale follows the close relationship between colorectal cancer surgery and the creation of temporary or permanent colostomies. Colorectal cancer remains one of the most common cancers worldwide, with an estimated 2 million new cases annually. The disposable ostomy bags industry relies on recurring use because many patients require ongoing management after surgery. Colostomy products, therefore, remain the core volume category.
Urostomy bags have the highest projected growth rate at 7.2% through 2031. Rising bladder cancer surgery volumes increase the need for urinary diversion products. Urinary diversions also have a lower reversal rate than intestinal ostomies, which extends the period of product use. Ileostomy bags maintain demand from Crohn’s disease and ulcerative colitis procedures. Inflammatory bowel disease rates are rising in areas that previously had lower disease burdens, including Southeast Asia and Latin America. Younger bladder cancer patients in parts of Asia may also raise demand for products that support active lifestyles.
Complete Report Scope:
- By Product Type
- One-Piece Disposable Ostomy Bags
- Two-Piece Disposable Ostomy Bags
- By Ostomy Type
- Colostomy Bags
- Ileostomy Bags
- Urostomy Bags
- By System Design
- Closed-End Systems
- Drainable Systems
- Flat Systems
- Convex Systems
- By Indication
- Colorectal Cancer
- Inflammatory Bowel Disease
- Bladder Cancer & Urinary Diversion
- Other Indications
- By End User
- Hospitals & Specialty Clinics
- Ambulatory Surgical Centers
- Home-Care Settings
- Long-Term Care Facilities
- Specialist Ostomy Clinics
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America held 41.8% of revenue in the disposable ostomy bags market in 2025. The region has a large insured patient base, including an estimated 750,000 to 1 million people with permanent or temporary ostomies in the United States. Medicare Part B supports a stable reimbursement foundation for ostomy supplies. The United Ostomy Associations of America stated that supplies remain covered and that competitive bidding is scheduled for 2028. Premium convex and two-piece products have strong regional uptake.Asia-Pacific is forecast to grow at a 7.5% CAGR through 2031, the fastest regional rate in the disposable ostomy bags market. China’s colorectal cancer burden, India’s hospital expansion, and Japan’s older population support regional demand. China has more than 1 million ostomy patients, with close to 100,000 new patients each year according to the source material. Japan combines an aging population with established reimbursement for stoma-care products, while South Korea, Australia, and New Zealand have well-developed branded product markets.
Europe has a substantial stoma population and established reimbursement structures, with Germany leading regional volumes. Coloplast reported double-digit growth in the United Kingdom during the first half of 2025/26, supported by SenSura Mio Convex. South America is led by Brazil as colorectal cancer treatment access improves. ConvaTec identified Latin America as a growth leader in its April 2026 trading update. The Middle East and Africa remain earlier-stage areas with rising awareness and more private hospital capacity.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET LANDSCAPE
5 MARKET SIZE AND GROWTH FORECASTS
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
